| First Author | Guo C | Year | 2015 |
| Journal | Hum Mol Genet | Volume | 24 |
| Issue | 7 | Pages | 1991-9 |
| PubMed ID | 25510506 | Mgi Jnum | J:219597 |
| Mgi Id | MGI:5621237 | Doi | 10.1093/hmg/ddu613 |
| Citation | Guo C, et al. (2015) A mouse model of urofacial syndrome with dysfunctional urination. Hum Mol Genet 24(7):1991-9 |
| abstractText | Urofacial syndrome (UFS) is an autosomal recessive disease with severe dysfunctional urination including urinary incontinence (UI). Biallelic mutations of HPSE2 are discovered from UFS patients, suggesting that HPSE2 is a candidate disease gene. Here, we show that deletion of Hpse2 is sufficient to cause the UFS-like phenotype in mice. Hpse2 knockout mutants display a distended bladder (megacystis) phenotype and abnormal voiding behavior similar to that found in patients. While Hpse2 is largely dispensable for detrusor smooth muscle and urothelial cell fate determination, the mutants have significantly lower rates of cell proliferation than wild-type littermate controls. All Hpse2 mutants have a growth retardation phenotype and die within a month after birth. Comprehensive blood chemistry and urinalysis indicate that Hpse2 mutants have renal dysfunction and malnutrition. We provide evidence that transforming growth factor beta (Tgfbeta) signaling is attenuated at birth. However, Tgfbeta activity is significantly enhanced at later stages when the urological phenotype is severe, and the mutant bladders have accumulated excessive amount of fibrotic tissue. Together, these findings strongly suggest that Hpse2 is a causative gene of human UFS and further uncover unexpected roles of Hpse2 in bladder physiology, tissue remodeling and Tgfbeta signaling. |
